X
FETP Dashboard
Image
Click on the dark blue Areas
Country Name AFGHANISTAN
Explore More

Year of Establishment

2019

Accreditation Status

NA

Visit Afghanistan FETP

Click here

Advanced Grads

NA

Intermediate Grads

125

Basic Grads

57

Outbreak Investigations Conducted

200+

Manuscripts Published

10

Participations in International Conferences

10

________________

Back To Map
Country Name BANGLADESH
Explore More

Year of Establishment

2013

Accreditation Status

NA

Visit Bangladesh FETP

Click here

Advanced Grads

37

Advanced Grads-Vet

35

Intermediate Grads

57

Basic Grads

97

Outbreak Investigation Conducted

212

Manuscripts Published

8

Participations in International Conferences

30

_

Back To Map

Year of Establishment

1993

Accreditation Status

Accredited

Visit Egypt FETP

Click here

Advanced Grads

174

Intermediate Grads

35

Basic Grads

202

Outbreak Investigation Conducted

200

Manuscripts Published

100+

Participations in International Conferences

50

_

Back To Map

Year of Establishment

2010

Accreditation Status

Accreditation

Visit Iraq FETP

Click here

Advanced Grads

76

Intermediate Grads

108

Basic Grads

339

Outbreak Investigation Conducted

387

Manuscripts Published

116

Participations in International Conferences

143

_

Back To Map
Year of Establishment 1998
Accreditation Status NA
Visit Jordan FETP Click here

Advanced Grads

129

Intermediate Grads

NA

Basic Grads

47

Outbreak Investigations Conducted

98

Manuscripts Published

29

Participations in International Conferences

338

_

Back To Map
Year of Establishment 2022
Accreditation Status NA
Visit Lebanon FETP Click here

Advanced Grads

NA

Intermediate Grads

NA

Basic Grads

130

Outbreak Investigation Conducted

NA

Manuscripts Published

NA

Participations in International Conferences

NA

_

Back To Map
Year of Establishment 2023
Accreditation Status NA
Visit Libya FETP NA

Advanced Grads

NA

Intermediate Grads

NA

Basic Grads

52

Outbreak Investigations Conducted

4

Manuscripts Published

NA

Participations in International Conferences

NA

_

Back To Map

Year of Establishment

2010

Accreditation Status

Accredited

Visit Morocco FETP

Click here

Advanced Grads

118

Intermediate Grads

45

Basic Grads

24

Outbreak Investigation Conducted

215

Manuscripts Published

12

Participations in International Conferences

70

_

Back To Map
Year of Establishment 2022
Accreditation Status NA
Visit Oman FETP NA

Advanced Grads

NA

Intermediate Grads

NA

Basic Grads

108

Outbreak Investigation Conducted

NA

Manuscripts Published

NA

Participations in International Conferences

NA

_

Back To Map

Year of Establishment

2006

Accreditation Status

Accredited

Visit Pakistan FELTP

Click here

Advanced Grads

349

Intermediate Grads

NA

Basic Grads

484

Outbreak Investigation Conducted

719

Manuscripts Published

166

Participations in International Conferences

240

_

Back To Map
Country Name QATAR

Year of Establishment

2022

Accreditation Status

NA

Visit Qatar FETP

NA

Advanced Grads

NA

Intermediate Grads

NA

Basic Grads

51

Outbreak Investigations Conducted

6

Manuscripts Published

26

Participations in International Conferences

25

_

Back To Map
Country Name SAUDI ARABIA
Explore More

Year of Establishment

1989

Accreditation Status

NA

Visit Saudi Arabia FETP

Click here

Advanced Grads

231

Intermediate Grads

NA

Basic Grads

30

Outbreak Investigations Conducted

141

Manuscripts Published

397

Participations in International Conferences

464

_

Back To Map

Year of Establishment

2017

Accreditation Status

NA

Visit Sudan FETP

Click here

Advanced Grads

23

Intermediate Grads

42

Basic Grads

166

Outbreak Investigations Conducted

59

Manuscripts Published

5

Participations in International Conferences

6

_

Back To Map

Year of Establishment

2017

Accreditation Status

NA

Visit Tunisia FETP

Click here

Advanced Grads

NA

Intermediate Grads

51

Basic Grads

36

Outbreak Investigation Conducted

33

Manuscripts Published

1

Participations in International Conferences

3

_

Back To Map

Year of Establishment

2011

Accreditation Status

NA

Visit Yemen FETP

Click here

Advanced Grads

56

Intermediate Grads

63

Basic Grads

534

Outbreak Investigations Conducted

59

Manuscripts Published

61

Participations in International Conferences

2

_

Back To Map
November 19, 2026
EMPHNET Webinar Highlights Technical Guidance and Country Experiences to Advance Maternal Tdap Vaccination in the EMR

Pertussis, commonly known as whooping cough, remains a significant public health challenge, particularly for young infants who face the greatest risk of severe illness, hospitalization, and death. With reported cases rising across the Eastern Mediterranean Region (EMR), maternal immunization has become increasingly important in strengthening prevention efforts.

 

Against this backdrop, EMPHNET held the 60th session of its WEBi Series, titled “From Evidence to Action: Technical Guidance for Introducing Maternal Tdap Vaccination in the EMR,” on November 10, 2026.

 

The webinar brought together 103 participants and featured international and regional experts who discussed scientific evidence, implementation experiences from Argentina and Oman, and EMPHNET's regional technical guidance.

 

The session was moderated by Dr. Ezzeddine Mohsni, Public Health International Expert in Vaccines and Immunization and Chair of the WHO EMR Regional Immunization Technical Advisory Group (RITAG).

 

Global and Regional Pertussis Trends: The Importance of Maternal Immunization

Dr. Flor Muñoz, Associate Professor of Pediatrics and Infectious Diseases at Baylor College of Medicine, USA, highlighted the resurgence of pertussis following the COVID-19 pandemic and its disproportionate impact on infants younger than two months, who are too young to receive their first routine pertussis vaccine doses.

 

She presented evidence demonstrating the effectiveness of maternal Tdap vaccination in protecting young infants, including a systematic review showing 69–91% effectiveness in preventing infant pertussis and 91–94% effectiveness in preventing hospitalizations. Read it here.

 

She also highlighted findings from a regional systematic review of 36 studies, which identified significant surveillance gaps and a high burden of severe disease among young infants in the EMR. Read it here.

 

Dr. Muñoz emphasized the importance of strengthening surveillance and routine immunization coverage, alongside expanding maternal Tdap vaccination to protect young infants.

 

Argentina's Experience: Translating Evidence into National Immunization Policy

Building on this evidence, Dr. Carla Vizzotti, Former Minister of Health of Argentina and Director of the Hub for Innovation in Health and Equity Policies, shared how Argentina translated concerns over infant pertussis deaths into national policy, introducing maternal Tdap vaccination in February 2012.

 

She reported that infant pertussis deaths declined from 74 in 2011 to four in 2014, while maternal vaccination coverage increased from 52% in 2012 to 83% in 2025, although disparities across provinces remain.

 

Dr. Vizzotti highlighted the importance of timely policy decisions, free and universal vaccine access, and integration into routine antenatal care. She also emphasized using available surveillance and mortality data to guide action while addressing monitoring and vaccination coverage gaps.

 

Oman: Five Years of Experience with Maternal Tdap Vaccination

Turning to the regional experience, Dr. Noura Al-Farsi, Head of the Immunization Program at Oman's Ministry of Health, shared lessons from Oman's introduction of maternal Tdap vaccination in August 2021 to protect infants before they receive their first routine vaccine doses.

 

She explained how Oman integrated vaccination into antenatal care and adjusted its recommended timing from 28 to 22 weeks of pregnancy. Maternal Tdap vaccination coverage reached 94% in 2025, alongside a reduction in reported pertussis cases among infants younger than two months.

 

Dr. Al-Farsi highlighted the role of national leadership, healthcare worker engagement, and accessible vaccination services, while identifying opportunities to strengthen laboratory surveillance, private sector reporting, and monitoring of infant outcomes.

 

EMPHNET Presents Technical Guidance for Introducing Maternal Tdap Vaccination in the EMR

Building on the international and regional experiences shared, Dr. Nada Ahmad, Director of the Center of Communication, Health Protection and Promotion at EMPHNET, presented the organization's technical guidance for introducing and scaling up maternal Tdap vaccination in the EMR.

 

She highlighted EMPHNET's work since 2023, including Expert Network Meetings held in 2024 and 2026 and two scientific publications: a systematic review on the burden of pertussis among infants in the EMR, published in BMC Public Health in 2025, and a paper outlining recommended actions for maternal pertussis immunization, published in the Journal of Health, Population and Nutrition in 2026. These efforts informed the development of the guidance presented during the webinar.

 

The guidance outlines five implementation phases:

  1. Policy and decision-making: Translating evidence into national recommendations and securing government support and financing.
  2. Governance and coordination: Strengthening collaboration among immunization programs, maternal health services, and other stakeholders.
  3. Operational readiness: Preparing vaccine supplies, cold chain capacity, healthcare workers, and data systems.
  4. Service delivery and implementation: Integrating maternal Tdap vaccination into routine antenatal care and strengthening community engagement.
  5. Monitoring and evaluation: Tracking vaccination coverage, safety, and disease outcomes to guide improvements.

 

Dr. Ahmad emphasized building on existing maternal immunization services and strengthening National Immunization Technical Advisory Groups (NITAGs) to support evidence-informed decisions and implementation.

 

Read EMPHNET's Technical Guidance for Introducing Maternal Tdap Vaccination in the EMR.

 

Audience Discussion

The webinar concluded with a moderated discussion on pertussis surveillance and changing disease trends, vaccine safety, and integrating Tdap into existing maternal immunization schedules. Participants also raised questions about evaluating vaccination programs and sustaining protection, while highlighting the importance of awareness, healthcare provider engagement, and community mobilization in improving vaccine uptake.

 

Key Takeaways

  • Maternal Tdap vaccination offers effective protection for young infants, particularly before they receive their first routine childhood vaccine doses.
  • Experiences from Argentina and Oman highlight the importance of timely, evidence-informed decisions, integration into routine antenatal care, and accessible vaccination services.
  • Strong surveillance, healthcare worker engagement, and continuous monitoring are essential for improving vaccination coverage, addressing implementation gaps, and assessing program outcomes.
  • EMPHNET's technical guidance provides a five-phase framework for introducing and implementing maternal Tdap vaccination, from national policy development and operational readiness to service delivery and evaluation.

 

The webinar was organized as part of EMPHNET's ongoing efforts under “The Way Forward for Pertussis Control in EMR: Focus on Maternal Immunization,” supported by Sanofi.

 

Watch the webinar recording here.

 

Explore more sessions from the EMPHNET WEBi Series.